Related Experiment Video
Updated: May 30, 2026

Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons
Published on: February 5, 2015
Host S-nitrosylation inhibits clostridial small molecule-activated glucosylating toxins
Tor C Savidge1, Petri Urvil, Numan Oezguen
1Department of Gastroenterology & Hepatology, University of Texas Medical Branch, Galveston, Texas, USA. tcsavidg@utmb.edu
Abstract:
The global prevalence of severe Clostridium difficile infection highlights the profound clinical significance of clostridial glucosylating toxins. Virulence is dependent on the autoactivation of a toxin cysteine protease, which is promoted by the allosteric cofactor inositol hexakisphosphate (InsP(6)). Host mechanisms that protect against such exotoxins are poorly understood. It is increasingly appreciated that the pleiotropic functions attributed to nitric oxide (NO), including host immunity, are in large part mediated by S-nitrosylation of proteins. Here we show that C. difficile toxins are S-nitrosylated by the infected host and that S-nitrosylation attenuates virulence by inhibiting toxin self-cleavage and cell entry. Notably, InsP(6)- and inositol pyrophosphate (InsP(7))-induced conformational changes in the toxin enabled host S-nitrosothiols to transnitrosylate the toxin catalytic cysteine, which forms part of a structurally conserved nitrosylation motif. Moreover, treatment with exogenous InsP(6) enhanced the therapeutic actions of oral S-nitrosothiols in mouse models of C. difficile infection. Allostery in bacterial proteins has thus been successfully exploited in the evolutionary development of nitrosothiol-based innate immunity and may provide an avenue to new therapeutic approaches.
Insights
Host nitric oxide (NO) protects against Clostridium difficile toxins by S-nitrosylation, inhibiting toxin activity. Inositol hexakisphosphate (InsP6) enhances this innate immunity, offering new therapeutic strategies for C. difficile infection.
Area of Science:
- Microbiology
- Immunology
- Biochemistry
Background:
- Severe Clostridium difficile infection is a significant global health concern, driven by potent glucosylating toxins.
- Toxin virulence relies on autoactivation of a cysteine protease, facilitated by inositol hexakisphosphate (InsP6).
- Host defense mechanisms against bacterial exotoxins are not fully understood, though nitric oxide (NO) plays a role in immunity via S-nitrosylation.
Purpose of the Study:
- To investigate host mechanisms for combating C. difficile toxins.
- To explore the role of nitric oxide (NO) and S-nitrosylation in C. difficile toxin regulation.
- To assess the therapeutic potential of S-nitrosothiols and InsP6 in C. difficile infection models.
Main Methods:
- Analysis of C. difficile toxin S-nitrosylation in infected hosts.
- Investigating the impact of S-nitrosylation on toxin self-cleavage and cell entry.
- Utilizing mouse models to evaluate the efficacy of exogenous InsP6 and S-nitrosothiols as treatments.
Main Results:
- C. difficile toxins are S-nitrosylated by the host, which inhibits their virulence.
- InsP6 and inositol pyrophosphate (InsP7) facilitate host S-nitrosothiols to modify the toxin's catalytic cysteine.
- Exogenous InsP6 amplified the therapeutic effect of oral S-nitrosothiols in mouse models of C. difficile infection.
Conclusions:
- Host S-nitrosylation serves as an innate immune defense against C. difficile toxins.
- Exploiting allosteric regulation of bacterial proteins, like C. difficile toxins, can lead to novel therapeutic strategies.
- Nitrosothiol-based therapies, potentially enhanced by InsP6, show promise for treating C. difficile infections.
Related Concept Videos
Botulism
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Gene Regulation in Microbial Communities: Quorum Sensing
Bacterial Toxins
Inhibitors of Bacterial DNA Synthesis

